Astonea Labs Limited (BOM:544409)
278.00
0.00 (0.00%)
At close: Aug 13, 2026
Astonea Labs Revenue
In the fiscal year ending March 31, 2026, Astonea Labs had annual revenue of 1.48B INR with 51.34% growth. Astonea Labs had revenue of 812.93M in the half year ending March 31, 2026.
Revenue
1.48B
Revenue Growth
+51.34%
P/S Ratio
1.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.48B | 500.66M | 51.34% |
| Mar 31, 2025 | 975.18M | 173.28M | 21.61% |
| Mar 31, 2024 | 801.91M | 131.40M | 19.60% |
| Mar 31, 2023 | 670.51M | 369.94M | 123.08% |
| Mar 31, 2022 | 300.57M | 7.30M | 2.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medico Remedies | 2.38B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Trident Lifeline | 1.39B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 996.09M |